Novel Peptide-drug Conjugate Melflufen Efficiently Eradicates Bortezomib-resistant Multiple Myeloma Cells Including Tumor-initiating Myeloma Progenitor Cells.
HemaSphere • Vol. 5, Issue 7 • 2021
Melflufen and Dexamethasone in Heavily Pretreated Relapsed and Refractory Multiple Myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology • Vol. 39, Issue 7 • 2021
Melphalan Flufenamide (Melflufen): First Approval.
Drugs • Vol. 81, Issue 8 • 2021
Melflufen for relapsed and refractory multiple myeloma.
Expert opinion on investigational drugs • Vol. 29, Issue 10 • 2020